Tharimmune (THAR) Institutional Ownership $2.17 -0.06 (-2.69%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tharimmune (NASDAQ:THAR)CurrentInstitutional OwnershipPercentage1.16%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$58.58KNumber ofInstitutional Sellers(last 12 months)0 Get THAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Tharimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad DTIWhy buying gold might be a mistakeSomething strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.If you're interested, check out the recording here while the link's still up. Tharimmune Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/6/2024 Curi RMB Capital LLC23,620$59K0.0%N/A2.056% (Data available from 1/1/2016 forward) THAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Tharimmune shares: Curi RMB Capital LLC ($59K).Learn more on THAR's institutional investors. What percentage of Tharimmune stock is owned by institutional investors? 1.16% of Tharimmune stock is owned by institutional investors. Learn more on THAR's institutional investor holdings. Which institutional investors have been buying Tharimmune stock? The following institutional investors have purchased Tharimmune stock in the last 24 months: Curi RMB Capital LLC ($23.62K). How much institutional buying is happening at Tharimmune? Institutional investors have bought a total of 23,620 shares in the last 24 months. This purchase volume represents approximately $58.58K in transactions. Related Companies Turnstone Biologics Institutional Ownership Sensei Biotherapeutics Institutional Ownership Trinity Biotech Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership Indaptus Therapeutics Institutional Ownership Addex Therapeutics Institutional Ownership Aytu BioPharma Institutional Ownership RedHill Biopharma Institutional Ownership Kiora Pharmaceuticals Institutional Ownership Biora Therapeutics Institutional Ownership This page (NASDAQ:THAR) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
